Clinical Applications of DNA Methylation Testing

Key Clinical Applications

DNA methylation testing enables detection and diagnosis of various cancers through identification of tumor-specific methylation patterns in tissue samples and cell-free DNA (cfDNA) 2, 3
The American College of Surgeons and other medical organizations support the use of DNA methylation-based assays, such as EGFR mutation detection in non-small cell lung cancer, PIK3CA mutation detection in breast cancer, and SEPT9 promoter methylation testing for colorectal cancer 4
DNA methylation profiling serves as the gold standard for brain tumor classification, particularly for medulloblastoma subtyping, which guides treatment decisions, as recommended by the National Comprehensive Cancer Network 5, 1
Cell-free DNA methylation analysis provides a minimally invasive "liquid biopsy" approach for cancer detection and monitoring treatment response, with a sensitivity of 64% when combined with additional protein biomarkers 2, 6

DNA methylation testing results can be affected by technical challenges such as PCR bias, low read coverage, and SNPs at CpG sites, highlighting the need for specialized expertise in test interpretation 1
The National Institutes of Health and other organizations emphasize the importance of harmonization in biospecimen collection, processing, and storage practices to ensure accurate test results 2, 6

The American College of Medical Genetics recommends that DNA methylation testing be performed at academic tertiary centers with specialized expertise, implementing proper quality control measures such as filtering based on coverage levels and correction for SNP genotypes 1
The National Comprehensive Cancer Network suggests that DNA methylation testing is most effective when used in combination with other biomarkers rather than as a standalone test, increasing screening sensitivity for pancreatic cancer from 30% to 64% 3, 6